{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T02:59:30Z","timestamp":1780714770423,"version":"3.54.1"},"reference-count":41,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["acrjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["ACR Open Rheumatology"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>We explored the relationship between achievement of clinical disease control and improvements in and normative values for patient\u2010reported outcomes (PROs), including quality of life (QoL) measures, in patients with psoriatic arthritis (PsA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This was a post hoc analysis of 104\u2010week data from the SELECT\u2010PsA 1 and 2 trials in adults with PsA and inadequate response to one or more conventional synthetic (SELECT\u2010PsA 1) or biologic (SELECT\u2010PsA 2) disease\u2010modifying antirheumatic drug. Patients were initially randomized to upadacitinib 15 mg once daily (QD) to placebo switched to upadacitinib 15 mg QD at week 24 or to adalimumab 40 mg every other week (SELECT\u2010PsA 1 only), and data were pooled across treatments and analyzed. We evaluated several clinical disease control measures (minimal disease activity [MDA]; very low disease activity [VLDA]; and low disease activity [LDA] and\/or remission by Disease Activity in Psoriatic Arthritis [DAPSA], Psoriatic Arthritis Disease Activity Score [PASDAS], and Routine Assessment of Patient Index Data 3 [RAPID3]) and examined their associations with improvements and normative values for various PROs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 1,069 and 317 patients were analyzed for SELECT\u2010PsA 1 and 2, respectively. In both studies, responders (patients who achieved MDA or VLDA, and DAPSA, PASDAS, and RAPID3 LDA or remission) at week 104 achieved more marked changes from baseline, and more responders achieved normative values in PROs compared with nonresponders (most nominal <jats:italic>P<\/jats:italic> &lt; 0.0001). Furthermore, numerically larger proportions of responders achieved minimal clinically important differences across PROs compared with nonresponders in both studies. In addition, patients who achieved MDA or VLDA were more likely to achieve DAPSA, PASDAS, and RAPID3 LDA or remission (all nominal <jats:italic>P<\/jats:italic> &lt; 0.0001) for upadacitinib 15 mg QD and when treatment arms were pooled.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Patients with PsA who achieve clinical disease control are more likely to achieve improvements and normative values in PROs and QoL measures, which reinforces disease control as a treatment target.<\/jats:p><\/jats:sec>","DOI":"10.1002\/acr2.11714","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T09:49:29Z","timestamp":1722505769000},"page":"736-745","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Association Between Achievement of Clinical Disease Control and Improvement in Patient\u2010Reported Outcomes and Quality of Life in Patients With Psoriatic Arthritis in the Phase 3 <scp>SELECT<\/scp>\u2010<scp>PsA<\/scp> 1 and 2 Randomized Controlled Trials"],"prefix":"10.1002","volume":"6","author":[{"given":"Arthur","family":"Kavanaugh","sequence":"first","affiliation":[{"name":"University of California San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6620-0457","authenticated-orcid":false,"given":"Philip","family":"Mease","sequence":"additional","affiliation":[{"name":"Swedish Medical Center\/Providence St. Joseph Health and University of Washington  Seattle"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-310X","authenticated-orcid":false,"given":"Laure","family":"Gossec","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, INSERM, and Piti\u00e9\u2010Salp\u00eatri\u00e8re Hospital, AP\u2010HP  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6855-2413","authenticated-orcid":false,"given":"Roberto","family":"Ranza","sequence":"additional","affiliation":[{"name":"Hospital de Clinicas Universidade Federal de Uberl\u00e2ndia  Uberl\u00e2ndia Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeyoshi","family":"Tsuji","sequence":"additional","affiliation":[{"name":"Nippon Life Hospital  Osaka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Douglas","sequence":"additional","affiliation":[{"name":"AbbVie Inc  North Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lane","sequence":"additional","affiliation":[{"name":"AbbVie Inc  North Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Lippe","sequence":"additional","affiliation":[{"name":"AbbVie Inc  North Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manish","family":"Mittal","sequence":"additional","affiliation":[{"name":"AbbVie Inc  North Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianming","family":"Gao","sequence":"additional","affiliation":[{"name":"AbbVie Inc  North Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arathi","family":"Setty","sequence":"additional","affiliation":[{"name":"AbbVie Inc  North Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Ciecinski","sequence":"additional","affiliation":[{"name":"AbbVie Inc  North Chicago Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Aletaha","sequence":"additional","affiliation":[{"name":"Medical University of Vienna  Vienna Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2571-788X","authenticated-orcid":false,"given":"Peter","family":"Nash","sequence":"additional","affiliation":[{"name":"Griffith University and Rheumatology Research Unit, Sunshine Coast  Brisbane Queensland Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,8]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00798-0"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217159"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.102053"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150826"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.122259"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201341"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23460"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2023-0530"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2021.06.008"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171406"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-7-25"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-018-0031-x"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022516"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218870"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2021-001838"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00305-z"},{"issue":"11","key":"e_1_2_8_18_1","first-page":"2286","article-title":"Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3\u2010year results from the open\u2010label extension of the randomised controlled phase 3 SELECT\u2010PsA 2 study","volume":"41","author":"Mease P","year":"2023","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"e_1_2_8_19_1","first-page":"275","article-title":"Efficacy and safety of upadacitinib in patients with psoriatic arthritis: 2\u2010year results from the phase 3 SELECT\u2010PsA 1 study","volume":"10","author":"McInnes IB","year":"2023","journal-title":"Rheumatol Ther"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00379-9"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00377-x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110845"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2016.01.002"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14310"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1179\/jmt.2008.16.4.82E"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110392"},{"issue":"4","key":"e_1_2_8_27_1","first-page":"307","article-title":"Normative data: their definition, interpretation, and importance for primary care physicians","volume":"22","author":"O'Connor PJ","year":"1990","journal-title":"Fam Med"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110546"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20048"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-013-0498-2"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-1-79"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20621"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-019-0155-5"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.2000"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-018-0030-y"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.03.015"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02474-2"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-017-0285-1"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-214140"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2022.105511"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2022-eular.1279"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2019-001002"}],"container-title":["ACR Open Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/acr2.11714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T15:23:36Z","timestamp":1759418616000},"score":1,"resource":{"primary":{"URL":"https:\/\/acrjournals.onlinelibrary.wiley.com\/doi\/10.1002\/acr2.11714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1002\/acr2.11714"],"URL":"https:\/\/doi.org\/10.1002\/acr2.11714","archive":["Portico"],"relation":{},"ISSN":["2578-5745","2578-5745"],"issn-type":[{"value":"2578-5745","type":"print"},{"value":"2578-5745","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"2024-06-11","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}